Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Albemarle Corporation (ALB)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
279.51+1.89 (+0.68%)
At close: 04:00PM EDT
279.50 -0.01 (-0.00%)
After hours: 07:54PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close277.62
Open278.90
Bid278.00 x 800
Ask280.50 x 1000
Day's Range275.92 - 282.00
52 Week Range169.93 - 291.48
Volume1,070,663
Avg. Volume1,367,398
Market Cap32.739B
Beta (5Y Monthly)1.58
PE Ratio (TTM)129.40
EPS (TTM)2.16
Earnings DateNov 01, 2022 - Nov 07, 2022
Forward Dividend & Yield1.58 (0.57%)
Ex-Dividend DateSep 15, 2022
1y Target Est288.95
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
14% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ALB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Albemarle Corporation
    Analyst Report: Albemarle Corp.Albemarle is a global manufacturer of highly engineered specialty chemicals for a wide range of markets. The company became a top manufacturer of lithium (used in a number of industries but particularly for batteries in electric cars) through its January 2015 acquisition of Rockwood Holdings. Its other leading products are bromine, which is used in fire safety solutions, and catalysts used in oil refining.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
Advertisement
Advertisement